世界癌症日:我们能!战胜癌症!

2016-02-04 Jeffrey MedSci原创

今天(2月4日)是世界癌症日,今年的主题是:WE CAN ! I CAN !是的!我们可以战胜癌症!中国癌症发展现状由国家癌症中心副主任赫捷院士、全国肿瘤登记中心主任陈万青等共同完成的《2015年中国癌症统计》估计,中国2015年新增430万癌症病例,癌症的死亡病例超过280万,其中肺癌是中国癌症死亡的主要原因。按照预计,平均每天新增癌症病例近1.2万例,有超过7500人死于癌症。报告显示,男性最

今天(2月4日)是世界癌症日,今年的主题是:WE CAN ! I CAN !



是的!我们可以战胜癌症!

中国癌症发展现状

由国家癌症中心副主任赫捷院士、全国肿瘤登记中心主任陈万青等共同完成的《2015年中国癌症统计》估计,中国2015年新增430万癌症病例,癌症的死亡病例超过280万,其中肺癌是中国癌症死亡的主要原因。按照预计,平均每天新增癌症病例近1.2万例,有超过7500人死于癌症。

报告显示,男性最为常见的5种癌症为肺癌、胃癌、食道癌、肝癌和结直肠癌,这5种癌症病例一起大约占全部癌症例的三分之二。女性最为常见的癌症是乳腺癌、肺癌、胃癌、结直肠癌和食道癌,其中乳腺癌病例可能单独占中国女性所有新增癌症病例的15%。

从2006年以来,虽然癌症死亡率显着下降,但随着人口老龄化的到来,癌症死亡人数将大量增加。要防止肿瘤高发,最重要的措施还是要做好必要的预防工作,早发现早治疗。

五大高发癌症的早期筛查

肺癌

高危人群:40岁以上,有肺癌家族史、有长期吸烟史者。

筛查方法:建议每年做一次低剂量CT筛查肺癌,如果CT发现肺部有阴影或结节,特别是磨玻璃样的阴影或结节,最好到正规大医院找有经验的医生看看,如果必要的话可以做个病理活检。

肠癌

高危人群:有肠癌家庭史,有大肠息肉病、大肠腺瘤、溃疡性结肠炎、克罗病等病史,高脂饮食,有长期吸烟史,长期大量饮酒者。

筛查方法:正常人群50岁以上可以每年做一次大便隐血、肿瘤标志物镜筛查。最好肠镜筛查,如果没有问题就间隔3~5年做一次肠镜。如果发现大便带血,不要认为是痔疮而掉以轻心,可咨询医生,必要时做个肠镜检查。

胃癌

高危人群:40岁以上、胃部家族史、幽门螺杆菌检测阳性、有慢性胃病史、长期吃腌制食品、长期吸烟史、长期大量饮酒者。

筛查方法:一旦出现上腹部不适、心窝隐痛、食后饱胀感,食欲不振、消瘦、乏力,经常呕吐隔夜宿食和不含胆汁的胃液,或有大便呈黑色柏油样等症状者,应及时做胃镜排查。对于没有出现任何胃部不适的年轻人,但三代以内直系亲属中有60岁以下死于胃癌者,最好每年做一次胃镜检查。没有高危因素的人,建议40岁以上每1~2年做一次胃镜检查。

肝癌

高危人群:有肝癌家庭史、五年以上乙肝患者,乙肝病毒携带者,40岁以上有慢性肝炎病史,肝硬化患者,长期嗜酒者。

筛查方法:可以使用B超和甲胎蛋白筛查,进一步明确诊断科做CT或磁共振检查。高危人群半年查一次,正常人群可一年做一次。如果出现食欲不振、恶心、腹胀、上腹部不适等,应尽快去医院就诊检查。

食管癌

高危人群:40岁以上,有食管癌家族史、长期吃烫食或腌制食品者。

筛查方法:最好每年做一次胃镜检查看看食管情况,发现异常可取活检病理检查。如果胃镜检查发现中重度不典型增生应特别注意。

科学的癌症预防

1.不要吸烟

吸烟与多种癌症发生有关,包括肺癌、口腔癌、胰腺癌、膀胱癌、宫颈癌及肾癌等。拒绝烟草,停止吸烟,是对癌症最好的预防。

2.健康饮食

l 多吃水果和蔬菜。多吃植物源食物,比如全谷物和豆类。
l 避免肥胖。少食用高卡路里食物,包括精制糖和动物脂肪。
l 适度饮酒。许多癌症发生与长期大量饮酒相关,包括肺癌、肾癌、肝癌、结肠癌和乳腺癌等。
l 限制食用加工肉类。WHO癌症机构表示,大量食用加工肉可增加某些癌症的发生风险。

另外,地中海饮食,补充特级橄榄油和混合坚果可以降低女性乳腺癌发生风险。

3.保持健康体重并进行体育锻炼

保持健康体重可以降低多种癌症发生风险。定期的体育锻炼有助于控制体重,可以降低乳腺癌和结肠癌发生风险。

保证每天至少有30分钟的健身时间。

4.避免日晒

皮肤癌是最常见的癌症之一,也是最可能预防的癌症之一。

l 避免正午阳光照射
l 户外运动尽量待在阴凉处
l 遮住身体暴露部分
l 外出涂防晒霜

5.接受免疫

癌症预防包括预防病毒感染。乙型肝炎可增加肝癌发生风险。乙型肝炎疫苗推荐用于静脉注射吸毒者、男男性行为者及其它可能接触感染血液或体液的人员。

人乳头状瘤病毒(HPV)是一种性传播病毒,可导致宫颈癌和其他生殖器肿瘤,以及头部和颈部的鳞状细胞癌。人乳头状瘤病毒疫苗推荐用于11岁女孩和12岁男孩。也推荐用于26岁及以下没有接种疫苗的青少年。

6.避免危险行为

另外一个有效的癌症预防措施是避免可导致感染的危险行为。例如:

安全性行为。限制性伴侣数量,使用避孕套。

不要共用针头。共用药物使用者的针头可导致患HIV、乙肝和丙肝,乙肝和丙肝可以增加患肝癌风险。

7.定期医疗护理

定期体检和癌症筛查,有助于早期发现癌症,提高治疗成功率。

从今天开始进行科学的癌症预防吧!

参考资料:

1.Cancer prevention: 7 tips to reduce your risk.Mayo Clinic, Nov 5, 2015.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=63350, encodeId=6ade63350e4, content=加油啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:46:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63349, encodeId=81fd63349b0, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:45:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63296, encodeId=3ece6329624, content=一定能,相信科学的不断发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24721662825, createdName=1ddf23d5m57(暂无匿称), createdTime=Fri Feb 05 02:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63294, encodeId=dc2263294a3, content=相信人类的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 05 00:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63273, encodeId=8395632e313, content=wecan!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLAibgOibuZnfdFE64hJHibbD6WwEgyaXx7DtibMOSicJ6JZoLEAIdAdkhDmHWO7P7OXg2tkTicZy9libryicw/0, createdBy=aa991670466, createdName=sword20000, createdTime=Thu Feb 04 22:01:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63239, encodeId=720d6323953, content=为抗癌贡献一份力量。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTISUH3xzQIz5VrIhTmepRL6oa3EYnPT61ll2ibYJAy3oeB7oJiaBAWF6opwu9Rod4yHsju1JmHroUOw/132, createdBy=23c71654813, createdName=长春碱, createdTime=Thu Feb 04 17:52:00 CST 2016, time=2016-02-04, status=1, ipAttribution=)]
    2016-02-05 1de47ca2m12(暂无匿称)

    加油啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=63350, encodeId=6ade63350e4, content=加油啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:46:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63349, encodeId=81fd63349b0, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:45:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63296, encodeId=3ece6329624, content=一定能,相信科学的不断发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24721662825, createdName=1ddf23d5m57(暂无匿称), createdTime=Fri Feb 05 02:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63294, encodeId=dc2263294a3, content=相信人类的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 05 00:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63273, encodeId=8395632e313, content=wecan!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLAibgOibuZnfdFE64hJHibbD6WwEgyaXx7DtibMOSicJ6JZoLEAIdAdkhDmHWO7P7OXg2tkTicZy9libryicw/0, createdBy=aa991670466, createdName=sword20000, createdTime=Thu Feb 04 22:01:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63239, encodeId=720d6323953, content=为抗癌贡献一份力量。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTISUH3xzQIz5VrIhTmepRL6oa3EYnPT61ll2ibYJAy3oeB7oJiaBAWF6opwu9Rod4yHsju1JmHroUOw/132, createdBy=23c71654813, createdName=长春碱, createdTime=Thu Feb 04 17:52:00 CST 2016, time=2016-02-04, status=1, ipAttribution=)]
    2016-02-05 1de47ca2m12(暂无匿称)

    加油

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=63350, encodeId=6ade63350e4, content=加油啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:46:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63349, encodeId=81fd63349b0, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:45:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63296, encodeId=3ece6329624, content=一定能,相信科学的不断发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24721662825, createdName=1ddf23d5m57(暂无匿称), createdTime=Fri Feb 05 02:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63294, encodeId=dc2263294a3, content=相信人类的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 05 00:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63273, encodeId=8395632e313, content=wecan!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLAibgOibuZnfdFE64hJHibbD6WwEgyaXx7DtibMOSicJ6JZoLEAIdAdkhDmHWO7P7OXg2tkTicZy9libryicw/0, createdBy=aa991670466, createdName=sword20000, createdTime=Thu Feb 04 22:01:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63239, encodeId=720d6323953, content=为抗癌贡献一份力量。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTISUH3xzQIz5VrIhTmepRL6oa3EYnPT61ll2ibYJAy3oeB7oJiaBAWF6opwu9Rod4yHsju1JmHroUOw/132, createdBy=23c71654813, createdName=长春碱, createdTime=Thu Feb 04 17:52:00 CST 2016, time=2016-02-04, status=1, ipAttribution=)]
    2016-02-05 1ddf23d5m57(暂无匿称)

    一定能,相信科学的不断发展

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=63350, encodeId=6ade63350e4, content=加油啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:46:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63349, encodeId=81fd63349b0, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:45:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63296, encodeId=3ece6329624, content=一定能,相信科学的不断发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24721662825, createdName=1ddf23d5m57(暂无匿称), createdTime=Fri Feb 05 02:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63294, encodeId=dc2263294a3, content=相信人类的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 05 00:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63273, encodeId=8395632e313, content=wecan!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLAibgOibuZnfdFE64hJHibbD6WwEgyaXx7DtibMOSicJ6JZoLEAIdAdkhDmHWO7P7OXg2tkTicZy9libryicw/0, createdBy=aa991670466, createdName=sword20000, createdTime=Thu Feb 04 22:01:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63239, encodeId=720d6323953, content=为抗癌贡献一份力量。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTISUH3xzQIz5VrIhTmepRL6oa3EYnPT61ll2ibYJAy3oeB7oJiaBAWF6opwu9Rod4yHsju1JmHroUOw/132, createdBy=23c71654813, createdName=长春碱, createdTime=Thu Feb 04 17:52:00 CST 2016, time=2016-02-04, status=1, ipAttribution=)]
    2016-02-05 dhzzm

    相信人类的力量

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=63350, encodeId=6ade63350e4, content=加油啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:46:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63349, encodeId=81fd63349b0, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:45:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63296, encodeId=3ece6329624, content=一定能,相信科学的不断发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24721662825, createdName=1ddf23d5m57(暂无匿称), createdTime=Fri Feb 05 02:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63294, encodeId=dc2263294a3, content=相信人类的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 05 00:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63273, encodeId=8395632e313, content=wecan!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLAibgOibuZnfdFE64hJHibbD6WwEgyaXx7DtibMOSicJ6JZoLEAIdAdkhDmHWO7P7OXg2tkTicZy9libryicw/0, createdBy=aa991670466, createdName=sword20000, createdTime=Thu Feb 04 22:01:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63239, encodeId=720d6323953, content=为抗癌贡献一份力量。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTISUH3xzQIz5VrIhTmepRL6oa3EYnPT61ll2ibYJAy3oeB7oJiaBAWF6opwu9Rod4yHsju1JmHroUOw/132, createdBy=23c71654813, createdName=长春碱, createdTime=Thu Feb 04 17:52:00 CST 2016, time=2016-02-04, status=1, ipAttribution=)]
    2016-02-04 sword20000

    wecan!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=63350, encodeId=6ade63350e4, content=加油啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:46:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63349, encodeId=81fd63349b0, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a6b1686125, createdName=1de47ca2m12(暂无匿称), createdTime=Fri Feb 05 11:45:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63296, encodeId=3ece6329624, content=一定能,相信科学的不断发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24721662825, createdName=1ddf23d5m57(暂无匿称), createdTime=Fri Feb 05 02:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63294, encodeId=dc2263294a3, content=相信人类的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 05 00:14:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63273, encodeId=8395632e313, content=wecan!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLAibgOibuZnfdFE64hJHibbD6WwEgyaXx7DtibMOSicJ6JZoLEAIdAdkhDmHWO7P7OXg2tkTicZy9libryicw/0, createdBy=aa991670466, createdName=sword20000, createdTime=Thu Feb 04 22:01:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63239, encodeId=720d6323953, content=为抗癌贡献一份力量。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTISUH3xzQIz5VrIhTmepRL6oa3EYnPT61ll2ibYJAy3oeB7oJiaBAWF6opwu9Rod4yHsju1JmHroUOw/132, createdBy=23c71654813, createdName=长春碱, createdTime=Thu Feb 04 17:52:00 CST 2016, time=2016-02-04, status=1, ipAttribution=)]
    2016-02-04 长春碱

    为抗癌贡献一份力量。

    0

相关资讯

ASCO 2015:年度“颁奖盛典”

1月20日,美国临床肿瘤学会(ASCO)在《临床肿瘤学杂志》(JClin Oncol)上在线发布了《ASCO年度报告:2015临床肿瘤学进展》,不仅保持了以往传统,对上一年的癌症预防、治疗和患者照护有重大影响的临床进展进行探讨,而且还首次发布ASCO年度进展(AdvanceoftheYear)。 年度进展 ASCO年度报告首次发布年度进展(Advanceof the